QVIDTVM Management LLC Raises Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

QVIDTVM Management LLC grew its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 23.7% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 261,063 shares of the medical instruments supplier’s stock after purchasing an additional 50,000 shares during the period. DENTSPLY SIRONA makes up about 5.2% of QVIDTVM Management LLC’s portfolio, making the stock its 6th biggest position. QVIDTVM Management LLC owned about 0.13% of DENTSPLY SIRONA worth $6,503,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of XRAY. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in DENTSPLY SIRONA by 44.2% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 141,117 shares of the medical instruments supplier’s stock valued at $4,684,000 after purchasing an additional 43,230 shares during the last quarter. Seven Eight Capital LP bought a new position in shares of DENTSPLY SIRONA during the first quarter valued at approximately $1,409,000. Illinois Municipal Retirement Fund raised its holdings in shares of DENTSPLY SIRONA by 369.9% in the first quarter. Illinois Municipal Retirement Fund now owns 123,580 shares of the medical instruments supplier’s stock worth $4,102,000 after buying an additional 97,281 shares during the period. Intech Investment Management LLC purchased a new stake in shares of DENTSPLY SIRONA in the first quarter worth approximately $1,202,000. Finally, Duality Advisers LP bought a new stake in shares of DENTSPLY SIRONA during the 1st quarter worth approximately $1,166,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. Needham & Company LLC reiterated a “buy” rating and set a $34.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, August 20th. Evercore ISI decreased their price objective on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, July 9th. Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a research note on Monday, July 22nd. Stifel Nicolaus decreased their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research note on Thursday, July 18th. Finally, Barrington Research reissued an “outperform” rating and issued a $36.00 price objective on shares of DENTSPLY SIRONA in a research note on Friday. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $33.22.

Read Our Latest Research Report on DENTSPLY SIRONA

DENTSPLY SIRONA Stock Down 2.3 %

Shares of NASDAQ XRAY opened at $26.29 on Friday. The stock has a market capitalization of $5.46 billion, a PE ratio of -59.75, a price-to-earnings-growth ratio of 1.25 and a beta of 1.00. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57. DENTSPLY SIRONA Inc. has a 12-month low of $23.58 and a 12-month high of $37.60. The stock’s fifty day simple moving average is $25.56 and its two-hundred day simple moving average is $27.86.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last posted its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.01). The company had revenue of $984.00 million during the quarter, compared to analysts’ expectations of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. DENTSPLY SIRONA’s revenue for the quarter was down 4.3% on a year-over-year basis. During the same quarter last year, the firm earned $0.51 EPS. As a group, analysts expect that DENTSPLY SIRONA Inc. will post 1.99 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be paid a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, September 27th. This represents a $0.64 annualized dividend and a dividend yield of 2.43%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -145.45%.

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

See Also

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.